The clinical trial “Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities (EUPHORIA)” is officially registered with as of July 2nd, 2020. Read the details here. There, you will find the study design, patient cohort information, the outcome measures and the eligibility criteria.

The clinical investigation aims to generate clinical data to support the use of Multispectral Optoacoustic Tomography (MSOT) in clinical practice, its inclusion in diagnostic guidelines and to support its reimbursement, specifically to
  • Further validate the application with respect to including ulcerative colitis patients
  • Prepare a study protocol for large-scale clinical validation study in inflammatory bowel disease (IBD)
  • Successfully execute the clinical validation study

  EUPHORIA has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 830965. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.